High transplant rates of highly sensitized recipients with virtual crossmatching in kidney paired donation

Transplantation. 2012 Oct 15;94(7):744-9. doi: 10.1097/TP.0b013e3182612967.

Abstract

Background: In kidney paired donation (KPD), flexibility in the allocation of incompatible pairs is required if a critical mass of pairs to efficiently find matches cannot be reached.

Methods: In the Australian KPD program, virtual crossmatch is used for the allocation of suitable donors to registered recipients. Matching is based on acceptable mismatches, and donors are excluded from matching to recipients with donor-specific antibodies (DSAs) greater than 2000 mean fluorescence intensity (MFI). Match and transplant rates in the first year of the program were reviewed with respect to recipient and donor characteristics, including blood group distribution, level of recipient's sensitization, and postallocation crossmatches.

Results: Four quarterly match runs were performed, which included 53 pairs and 2 altruistic donors. Human leukocyte antigen incompatibility accounted for 90% of the listed pairs. In the second run, the DSA threshold was increased to greater than 8000 MFI, because no matches were found with standard allocation. Optional ABO-incompatible matching was introduced from run 3. Matches were identified in 37 (70%) patients, of whom 92% had a negative crossmatch with their matched donor. Crossmatch positive results were found only in recipients with DSAs greater than 2000 MFI in the second run. In 4 cases immunological reasons and in 4 cases other reasons resulted in breakdown of chains and 17 patients not progressing to transplantation. Eventually, 20 (38%) patients received a KPD transplant, and 35% of these had a calculated panel-reactive antibody greater than 90%.

Conclusions: KPD using virtual crossmatch is a valid and effective solution for patients with immunologically incompatible donors even in the context of highly sensitized recipients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ABO Blood-Group System / immunology
  • Algorithms
  • Altruism
  • Australia
  • Blood Group Incompatibility / immunology
  • Donor Selection
  • HLA Antigens / immunology*
  • Histocompatibility Testing
  • Histocompatibility*
  • Humans
  • Isoantibodies / blood*
  • Kidney Transplantation / immunology*
  • Living Donors*
  • Program Evaluation
  • Time Factors
  • Tissue and Organ Procurement
  • Treatment Outcome

Substances

  • ABO Blood-Group System
  • HLA Antigens
  • Isoantibodies